IQV IQVIA Holdings Inc.

250.55USD-2.83%Mkt Cap: 41.29B USDP/E: 30.48

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates …

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap41.29B USD
Enterprise Value55.31B USD
Revenue (TTM)17.31B USD
Gross Profit5.43B USD
Net Income (TTM)1.36B USD
Revenue/Share103.50 USD
Last Price250.55 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees95.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)30.48
P/E (Forward)17.64
PEG0.96
EV/EBITDA17.74
EV/Revenue3.20
P/S2.39
P/B6.20
EPS (TTM)8.22 USD
EPS (Forward)14.20 USD
52W Range
154.5074% of range284.50
52W High284.50 USD
52W Low154.50 USD
Profitability
Gross Margin33.29%
Oper. Margin13.89%
EBITDA Margin18.01%
Profit Margin8.34%
ROE20.91%
ROA4.54%
ROIC—
ROCE10.59%
Growth
Revenue Growth8.00%
Earnings Growth8.80%
Cash Flow & Leverage
Operating CF2.65B USD
CapEx (TTM)603.00M USD
FCF Margin12.22%
FCF Yield5.12%
Net Debt13.89B USD
Net Debt/EBITDA4.46
Net Debt/FCF6.57
Balance Sheet
Debt/Equity2.14
Current Ratio0.83
Quick Ratio0.74
Book Value/Sh40.41 USD
Cash/Share14.70 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)311.89 USD
Upside (mean)+24.5%
Target Range268.00 USD – 346.00 USD
268.00+24.5% to mean346.00
# Analysts18
Ownership
Shares Out.164.80M
Float156.44M
Insiders1.13%
Institutions102.78%
Short Interest
Short Ratio2.2d
Short % Float2.14%
Short % Out.1.85%
Shares Short3.04M
Short (prev mo.)3.22M
Technical
SMA 50267.34 (-6.3%)
SMA 200211.60 (+18.4%)
Beta1.17
S&P 52W Chg12.00%
Avg Vol (30d)1.34M
Avg Vol (10d)1.47M
Technical Indicators
RSI (14)35.4
MACD-2.1824
MACD Signal0.1302
MACD Hist.-2.3126
BB Upper284.46 USD
BB Middle268.15 USD
BB Lower251.84 USD
BB Width12.16%
ATR (14)8.707 USD
Vol Ratio (20d)0.89x

About IQVIA Holdings (NYSE: IQV)

›

IQVIA Holdings (NYSE: IQV) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 95,000 employees.

The shares were at 250.55 USD on 19 November 2026, up 13.6% over 52 weeks. Its 52-week range is 154.50 USD to 284.50 USD: the price is 11.9% below the high and 62.2% above the low.

At a market capitalisation of 41.29B USD, it trades at 30.5 times trailing earnings and 17.6 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 34.6, a discount of 12% for IQV.

IQVIA Holdings reports return on equity of 20.9%, an operating margin of 13.9% and revenue up 8.0% year over year.

Its debt exceeds its cash by 13.89B USD, a debt-to-equity ratio of 2.14. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 18 analysts cover the stock; their mean price target of 311.89 USD is 24.5% above the current price. The next earnings report is expected on 11 February 2027.